Hanmi Pharm Co Ltd
Hanmi Pharm's GHG Emissions Data Preview
In 2024, Hanmi Pharm completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Hanmi Pharm has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Hanmi Pharm’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Hanmi Pharm’s data sources below and access millions more through our Disclosure Search.
Insights into Hanmi Pharm's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Hanmi Pharm amounted to 71,772.022 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Hanmi Pharm increased by 17.2%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Hanmi Pharm's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Hanmi Pharm's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Hanmi Pharm were 13,514.933 metric tons of CO₂ equivalent (tCO₂e). a
Has Hanmi Pharm reduced its Scope 1 emissions over time?
Since 2021, Hanmi Pharm's Scope 1 emissions have increased by 37.36%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Hanmi Pharm's Scope 1 emissions increased by 17.32%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Hanmi Pharm's Scope 2 emissions?
In 2024, Hanmi Pharm reported Scope 2 greenhouse gas (GHG) emissions of 58,257.089 tCO₂e without specifying the calculation method. a
Has Hanmi Pharm reduced its Scope 2 emissions over time?
Since 2021, Hanmi Pharm's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 20.88%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2023), Hanmi Pharm's Scope 2 emissions (Unspecified Calculation Method) rose by 17.17% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Hanmi Pharm use for Scope 2 reporting?
In 2024, Hanmi Pharm reported its Scope 2 emissions using an unspecified methodology. a
Hanmi Pharm's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Hanmi Pharm's Value Chain Emissions
In 2024, Hanmi Pharm reported 88,703.298 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Hanmi Pharm includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Hanmi Pharm's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Hanmi Pharm's Scope 3 emissions?
In 2024, Hanmi Pharm reported total Scope 3 emissions of 88,703.298 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 82.46% of these emissions originated from upstream activities such as purchased goods and capital goods, while 17.54% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2023), Hanmi Pharm's Scope 3 emissions remained relatively stable, indicating that Hanmi Pharm 's emissions have plateaued with no significant change in its value chain footprint. a
What categories of Scope 3 emissions does Hanmi Pharm disclose?
In 2024, Hanmi Pharm reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Hanmi Pharm's Scope 3 emissions?
In 2024, the largest contributors to Hanmi Pharm's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 49,467.161 tCO₂e (55.77%)
- Investments (Cat. 15): 15,561.46 tCO₂e (17.54%)
- Capital Goods (Cat. 2): 7,980.585 tCO₂e (9%)
Hanmi Pharm's Scope 3 Emissions by Categories
Insights into Hanmi Pharm’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Hanmi Pharm reported Scope 1 greenhouse gas (GHG) emissions of 13,514.933 tCO₂e and total revenues of USD 1,019 millions. This translates into an emissions intensity of 13.26 tCO₂e per millions USD. a
Hanmi Pharm's Scope 1 Emissions Intensity Compared to Peers
How does Hanmi Pharm's GHG emissions intensity compare to its peers?
In 2024, Hanmi Pharm reported a Scope 1 emissions intensity of 13.26 tCO₂e per millions USD. Compared to the peer group median of 12.76 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Hanmi Pharm rank on GHG emissions intensity within its industry?
In 2024, Hanmi Pharm ranked 14 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Hanmi Pharm is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into Hanmi Pharm's Total Carbon Footprint
In 2024, Hanmi Pharm reported a total carbon footprint of 160,475.32 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 11.6% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Hanmi Pharm's total carbon footprint was Scope 3 emissions, accounting for 55.28% of the company's total carbon footprint, followed by Scope 2 emissions at 36.3%. a